InvestorsHub Logo
Followers 30
Posts 2777
Boards Moderated 3
Alias Born 10/24/2015

Re: None

Sunday, 11/03/2019 3:23:18 PM

Sunday, November 03, 2019 3:23:18 PM

Post# of 77
The company will host an investor event to review the safety, efficacy, and biomarker data from part one of the PhI/II trial of RP1 alone and in combination with Opdivo. The event will include a presentation by Dr. Coffin, President and CEO who will be joined by the PI, Prof. Middleton, and other senior members of the company's management team. The presentation will focus on the data being presented at SITC as well as additional supporting data from the trial.

The presentation will begin at 6:30 p.m. ET on Friday the 8th.

A simultaneous webcast will be available in the Investors section https://ir.replimune.com/events-and-presentations/upcoming-events A replay will be available for 30 days following the conference
Volume:
Day Range:
Bid:
Ask:
Last Trade Time:
Total Trades:
  • 1D
  • 1M
  • 3M
  • 6M
  • 1Y
  • 5Y
Recent REPL News